Jack Elands

Jack Elands

Company: Emergence Therapeutics

Job title: Chief Executive Officer

Seminars:

Nectin-4, An Ideal ADC Target, or Maybe Not? 10:00 am

• Providing a description of Nectin-4 biology and its relevance to oncology • Reviewing challenges to be addressed for an ADC • Sharing key learnings and relevance for other targetsRead more

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.